James W. McCollum net worth and biography

James McCollum Biography and Net Worth

Director of LENZ Therapeutics

James McCollum co-founded LENZ and has served on the LENZ board of directors since July 2013. From September 2016 to March 2021, Mr. McCollum served as LENZ’s President and Chief Executive Officer. From September 2014 to September 2016, Mr. McCollum served as President and Chief Executive Officer of Eye Therapies, LLC, an ocular pharmaceutical company co-founded by Mr. McCollum.

What is James W. McCollum's net worth?: The estimated net worth of James W. McCollum is at least $292.95 thousand as of November 7th, 2025. Mr. McCollum owns 10,500 shares of LENZ Therapeutics stock worth more than $292,950 as of December 4th. This net worth estimate does not reflect any other assets that Mr. McCollum may own. Learn More about James W. McCollum's net worth.
How old is James W. McCollum?: Mr. McCollum is currently 69 years old. There are 5 older executives and no younger executives at LENZ Therapeutics. The oldest executive at LENZ Therapeutics is Mr. Marvin J. Garrett, Senior Vice President of Regulatory & Quality, who is 73 years old. Learn More on James W. McCollum's age.
How do I contact James W. McCollum?: The corporate mailing address for Mr. McCollum and other LENZ Therapeutics executives is 611 Gateway Blvd Suite 120, SOUTH SAN FRANCISCO CA, 94080. LENZ Therapeutics can also be reached via phone at 650-484-0886 and via email at [email protected]. Learn More on James W. McCollum's contact information.
Has James W. McCollum been buying or selling shares of LENZ Therapeutics?: During the past quarter, James W. McCollum has bought $239,295.00 in shares of LENZ Therapeutics stock. Most recently, on Friday, November 7th, James W. Mccollum bought 10,500 shares of LENZ Therapeutics stock. The stock was acquired at an average cost of $22.79 per share, with a total value of $239,295.00. Following the completion of the transaction, the director now directly owns 10,500 shares of the company's stock, valued at $239,295. Learn More on James W. McCollum's trading history.
Are insiders buying or selling shares of LENZ Therapeutics?: In the last twelve months, LENZ Therapeutics insiders bought shares 2 times. They purchased a total of 12,698 shares worth more than $289,321.48. In the last twelve months, insiders at the sold shares 1 times. They sold a total of 10,000 shares worth more than $261,000.00. The most recent insider tranaction occured on November, 17th when insider Shawn Olsson sold 10,000 shares worth more than $261,000.00. Insiders at LENZ Therapeutics own 6.9% of the company. Learn More about insider trades at LENZ Therapeutics.
Information on this page was last updated on 11/17/2025.

James W. McCollum Insider Trading History at LENZ Therapeutics

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/7/2025	Buy	10,500	$22.79	$239,295.00	10,500
5/13/2024	Buy	31,332	$15.99	$500,998.68	525,565

James W. McCollum Buying and Selling Activity at LENZ Therapeutics

LENZ Therapeutics Company Overview

LENZ Therapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies to improve vision in the United States. Its product candidates include LNZ100 and LNZ101 which are in Phase III clinical trials for the treatment of presbyopia. The company is headquartered in Del Mar, California.

Today's Range

Now: $27.90

$27.65

$29.02

50 Day Range

MA: $33.59

$21.47

$49.05

2 Week Range

Now: $27.90

$16.53

$50.40

Volume

498,918 shs

Average Volume

1,024,788 shs

Market Capitalization

$872.99 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.46